The impact of the COVID-19 pandemic on non-COVID induced sepsis survival
Publié dans: | BMC Anesthesiology 22(2022)S. 12 |
---|---|
Auteurs principaux: | Unterberg, Matthias (Auteur), Rahmel, Tim (Auteur), Köhler, Thomas (Auteur), Henzler, Dietrich (Auteur), Schwier, Elke (Auteur) |
Format: | Article |
Langue: | English |
Publié: |
2022
|
Sujets: | |
Accès en ligne: | https://doi.org/10.1186/s12871-021-01547-8 |
Documents similaires: | In:
BMC Anesthesiology |
Documents similaires
-
Dosing of Antimycotic Treatment in Sepsis-Induced Liver Dysfunction by Functional Liver Testing with LiMAx
par: Kirchner, Carmen, et autres
Publié: (2019) -
Does adjunctive hemoadsorption with CytoSorb affect survival of COVID-19 patients on ECMO? A critical statement
par: Köhler, Thomas, et autres
Publié: (2021) -
Interrupted Chain of Transmission in a Pediatric COVID-19 Case
par: Grautoff, Steffen
Publié: (2020) -
Hemoadsorption with CytoSorb and the early course of linezolid plasma concentration during septic shock
par: Köhler, Thomas, et autres
Publié: (2022) -
Profound decrease of liver maximum function capacity test of isoflurane sedated patients : a report of three cases
par: Schwier, Elke, et autres
Publié: (2021)